Quick Answer
Verrica Pharmaceuticals Inc. reported Shares Outstanding of 17.18 million shares for fiscal year 2025.
Verrica Pharmaceuticals Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 17.18M | +87.2% |
| 2024 | 9.18M | -78.4% |
| 2023 | 42.41M | +3.2% |
| 2022 | 41.09M | +49.3% |
| 2021 | 27.52M | +8.2% |
| 2020 | 25.44M | -1.3% |
| 2019 | 25.79M | +0.3% |
| 2018 | 25.70M | +594.8% |
| 2017 | 3.70M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 9.49M | -79.2% | +2.5% |
| June 30, 2025 | 9.25M | -78.2% | -89.9% |
| March 31, 2025 | 91.79M | +116.4% | +900.1% |
| December 31, 2024 | 9.18M | -78.4% | -79.9% |
| September 30, 2024 | 45.60M | +8.4% | +7.4% |
| June 30, 2024 | 42.46M | +1.4% | +0.1% |
| March 31, 2024 | 42.42M | +1.4% | +0.0% |
| December 31, 2023 | 42.41M | +3.2% | +0.8% |
- Verrica Pharmaceuticals Inc. showed an increase of +87.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Verrica Pharmaceuticals Inc.’s shares outstanding has grown by 364.4% (from 3.70 million shares to 17.18 million shares).
- The most recent figure is from Verrica Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: